GPR152
gene geneOn this page
Also known as PGR5
Summary
GPR152 (G protein-coupled receptor 152, HGNC:23622) is a protein-coding gene on chromosome 11q13.2, encoding Probable G-protein coupled receptor 152 (Q8TDT2). Orphan receptor.
Enables identical protein binding activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Predicted to be located in membrane. Predicted to be active in plasma membrane.
Source: NCBI Gene 390212 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 61 total
- Druggable target: yes
- MANE Select transcript:
NM_206997
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23622 |
| Approved symbol | GPR152 |
| Name | G protein-coupled receptor 152 |
| Location | 11q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PGR5 |
| Ensembl gene | ENSG00000175514 |
| Ensembl biotype | protein_coding |
| Entrez | 390212 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000312457
RefSeq mRNA: 1 — MANE Select: NM_206997
NM_206997
CCDS: CCDS8165
Canonical transcript exons
ENST00000312457 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001185972 | 67451301 | 67452729 |
Expression profiles
Bgee: expression breadth tissue_specific, 8 present calls, max score 59.83.
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow cell | CL:0002092 | 59.83 | gold quality |
| granulocyte | CL:0000094 | 55.98 | gold quality |
| bone marrow | UBERON:0002371 | 47.61 | gold quality |
| colonic epithelium | UBERON:0000397 | 46.34 | gold quality |
| sural nerve | UBERON:0015488 | 44.03 | gold quality |
| spleen | UBERON:0002106 | 39.54 | silver quality |
| tonsil | UBERON:0002372 | 39.11 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 38.05 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| lymph node | UBERON:0000029 | 36.45 | gold quality |
| monocyte | CL:0000576 | 35.82 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.65 | gold quality |
| mucosa of stomach | UBERON:0001199 | 35.60 | silver quality |
| small intestine Peyer’s patch | UBERON:0003454 | 35.60 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| vermiform appendix | UBERON:0001154 | 35.36 | gold quality |
| small intestine | UBERON:0002108 | 35.28 | gold quality |
| muscle tissue | UBERON:0002385 | 34.50 | gold quality |
| liver | UBERON:0002107 | 31.91 | gold quality |
| body of stomach | UBERON:0001161 | 30.29 | silver quality |
| stomach | UBERON:0000945 | 30.24 | silver quality |
| lung | UBERON:0002048 | 29.96 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| placenta | UBERON:0001987 | 29.61 | gold quality |
| right uterine tube | UBERON:0001302 | 29.12 | gold quality |
| uterine cervix | UBERON:0000002 | 28.99 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 28.88 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 28.67 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.32 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gpr152 | ENSMUSG00000044724 |
| rattus_norvegicus | Gpr152 | ENSRNOG00000021912 |
Paralogs (10): MAS1 (ENSG00000130368), MRGPRX1 (ENSG00000170255), MRGPRF (ENSG00000172935), MRGPRD (ENSG00000172938), MRGPRX4 (ENSG00000179817), MRGPRX3 (ENSG00000179826), MRGPRG (ENSG00000182170), MRGPRX2 (ENSG00000183695), MRGPRE (ENSG00000184350), MAS1L (ENSG00000204687)
Protein
Protein identifiers
Probable G-protein coupled receptor 152 — Q8TDT2 (reviewed: Q8TDT2)
Alternative names: G-protein coupled receptor PGR5
All UniProt accessions (2): Q8TDT2, A0A0I9RJ67
UniProt curated annotations — full annotation on UniProt →
Function. Orphan receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_996880* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR026234 | MRGPCRFAMILY | Family |
Pfam: PF00001
UniProt features (23 total): topological domain 8, transmembrane region 7, compositionally biased region 3, region of interest 2, chain 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TDT2-F1 | 71.72 | 0.36 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 104–182
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 23 (showing top):
chr11q13, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, MARTENS_TRETINOIN_RESPONSE_DN, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D, RAO_BOUND_BY_SALL4_ISOFORM_B, GSE11924_TH2_VS_TH17_CD4_TCELL_DN, ZBED5_TARGET_GENES, ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE, GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY, GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP, GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN
GO Biological Process (2): G protein-coupled receptor signaling pathway (GO:0007186), signal transduction (GO:0007165)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| protein binding | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
666 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPR152 | GLIS3 | Q8NEA6 | 791 |
| GPR152 | GPR108 | Q9NPR9 | 632 |
| GPR152 | GPR171 | O14626 | 578 |
| GPR152 | GPR158 | Q5T848 | 525 |
| GPR152 | PPP1R26 | Q5T8A7 | 524 |
| GPR152 | GPR148 | Q8TDV2 | 514 |
| GPR152 | GPHRA | B7ZAQ6 | 508 |
| GPR152 | GPR162 | Q16538 | 507 |
| GPR152 | PTRH1 | Q86Y79 | 498 |
| GPR152 | GPR82 | Q96P67 | 490 |
| GPR152 | GPR139 | Q6DWJ6 | 480 |
| GPR152 | TMEM134 | Q9H6X4 | 477 |
| GPR152 | CABP4 | P57796 | 456 |
| GPR152 | TOR2A | Q5JU69 | 454 |
| GPR152 | GPR137 | Q96N19 | 446 |
IntAct
577 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMPPE | GPR152 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ABCG4 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPR152 | SLC13A4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GPR152 | CLN5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| VAMP4 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MGLL | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MMD | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM208 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EDDM3B | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PIGF | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM97 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TIMMDC1 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM243 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| INSIG2 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM50B | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SYT15 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SACM1L | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CYB561A3 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GPR152 | ABHD16A | psi-mi:“MI:0915”(physical association) | 0.000 |
| RABAC1 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LHFPL2 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CLEC17A | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| IGF2 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BNIP2 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMCO4 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| YIPF1 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GJB2 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCDC167 | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PTPRN | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LTC4S | GPR152 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (199): GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid), GPR152 (Two-hybrid)
ESM2 similar proteins: A0A0R4IP11, O00421, O14931, O15218, O15533, O35457, O60883, O88186, P33076, P61484, P79621, Q16570, Q16671, Q17QD8, Q3U3F9, Q5BK54, Q5TJE4, Q61790, Q6PZD2, Q7TQP4, Q7TSN6, Q7Z7M1, Q80SS6, Q80T02, Q863H8, Q8BL07, Q8BXQ3, Q8BXS7, Q8IZF5, Q8K1T1, Q8MII8, Q8MJ02, Q8N386, Q8TDT2, Q8TDU6, Q8TDV2, Q95LF2, Q95LF3, Q95LF4, Q95LF5
Diamond homologs: A0A4W3GG95, A0A6I8PUB9, B2GV46, B5X337, D4A7K7, E7FEL0, E9QJ73, F8VQN3, O00270, O08726, O08858, O14842, O14843, O15529, O42179, O43603, O46685, O60755, O77408, O88410, O88626, O88634, O88853, P21109, P23944, P25024, P25025, P35344, P35383, P35414, P41231, P41232, P46092, P46093, P49652, P49682, P49683, P50132, P51675, P51679
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 157 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| vesicle fusion | 5 | 22.5× | 2e-03 |
| cholesterol biosynthetic process | 5 | 15.7× | 6e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 51 |
| Likely benign | 10 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
60 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:67451834:C:CT | acceptor_gain | 0.5000 |
| 11:67452135:T:TA | donor_gain | 0.5000 |
| 11:67452142:T:TA | donor_gain | 0.4500 |
| 11:67451829:C:CC | acceptor_gain | 0.4100 |
| 11:67451902:C:CA | donor_gain | 0.4000 |
| 11:67452636:C:CT | donor_gain | 0.3900 |
| 11:67451828:A:AC | acceptor_gain | 0.3700 |
| 11:67451642:GTTCA:G | donor_loss | 0.3600 |
| 11:67451643:TTCA:T | donor_loss | 0.3600 |
| 11:67451644:TCACC:T | donor_loss | 0.3600 |
| 11:67451645:CAC:C | donor_loss | 0.3600 |
| 11:67451646:A:T | donor_loss | 0.3600 |
| 11:67451647:C:A | donor_loss | 0.3600 |
| 11:67451648:C:A | donor_loss | 0.3600 |
| 11:67451928:T:TA | donor_gain | 0.3600 |
| 11:67451929:C:A | donor_gain | 0.3600 |
| 11:67452213:T:TG | acceptor_gain | 0.3600 |
| 11:67451649:T:C | donor_loss | 0.3500 |
| 11:67451650:GAGGC:G | acceptor_gain | 0.3500 |
| 11:67451835:A:C | acceptor_gain | 0.3500 |
| 11:67452637:C:CT | donor_gain | 0.3500 |
| 11:67451901:T:TA | donor_gain | 0.3400 |
| 11:67452214:C:A | acceptor_gain | 0.3400 |
| 11:67451610:G:C | donor_gain | 0.3300 |
| 11:67451641:GGTTC:G | donor_loss | 0.3300 |
| 11:67452197:C:CT | donor_gain | 0.3300 |
| 11:67451599:G:C | donor_gain | 0.3100 |
| 11:67451832:GCCA:G | acceptor_gain | 0.3000 |
| 11:67451834:C:T | acceptor_gain | 0.3000 |
| 11:67451832:G:A | donor_gain | 0.2900 |
AlphaMissense
2982 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:67452434:C:A | W97C | 0.995 |
| 11:67452434:C:G | W97C | 0.995 |
| 11:67452509:G:C | S72R | 0.992 |
| 11:67452509:G:T | S72R | 0.992 |
| 11:67452511:T:G | S72R | 0.992 |
| 11:67452236:G:C | S163R | 0.990 |
| 11:67452236:G:T | S163R | 0.990 |
| 11:67452238:T:G | S163R | 0.990 |
| 11:67452347:G:C | S126R | 0.989 |
| 11:67452347:G:T | S126R | 0.989 |
| 11:67452349:T:G | S126R | 0.989 |
| 11:67452414:C:T | C104Y | 0.987 |
| 11:67452179:G:C | C182W | 0.985 |
| 11:67452180:C:T | C182Y | 0.985 |
| 11:67452436:A:G | W97R | 0.985 |
| 11:67452436:A:T | W97R | 0.985 |
| 11:67452413:G:C | C104W | 0.983 |
| 11:67452414:C:G | C104S | 0.983 |
| 11:67452415:A:T | C104S | 0.983 |
| 11:67452180:C:G | C182S | 0.982 |
| 11:67452181:A:T | C182S | 0.982 |
| 11:67452181:A:G | C182R | 0.981 |
| 11:67452598:C:G | G43R | 0.981 |
| 11:67452598:C:T | G43R | 0.981 |
| 11:67452259:A:G | W156R | 0.978 |
| 11:67452259:A:T | W156R | 0.978 |
| 11:67451861:G:C | S288R | 0.977 |
| 11:67451861:G:T | S288R | 0.977 |
| 11:67451863:T:G | S288R | 0.977 |
| 11:67452415:A:G | C104R | 0.976 |
dbSNP variants (sampled 300 via entrez): RS1000829672 (11:67453427 C>A), RS1002268917 (11:67452439 G>A,C), RS1002333604 (11:67450885 G>A,C), RS1003199431 (11:67454310 C>T), RS1003504971 (11:67452192 T>C), RS1003935148 (11:67451335 C>A,T), RS1006422325 (11:67450908 C>T), RS1008631970 (11:67453682 T>A,G), RS1011028115 (11:67451064 CTGTG>C,CTG), RS1011176578 (11:67452944 C>G,T), RS1013205351 (11:67450850 G>A), RS1013487922 (11:67452393 C>T), RS1014073489 (11:67454505 G>A), RS1014542338 (11:67454293 G>A,C), RS1015129780 (11:67451159 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003810_1 | Non-response to citalopram or escitalopram and depression | 1.000000e-06 |
| GCST010002_241 | Refractive error | 3.000000e-13 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523900 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with no pharmacology
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883421 | Binding | PRESTO-Tango GPCRome screening (GPR152) | Data for DCP probe UCSF924 |
Cellosaurus cell lines
2 cell lines: 1 spontaneously immortalized cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KX42 | PathHunter CHO-K1 GPR152 beta-arrestin | Spontaneously immortalized cell line | Female |
| CVCL_KZ53 | PathHunter HEK 293 GPR152 beta-arrestin | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mood disorder